TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10768906

Group type: EXPERIMENTAL
Intervention: Intracoronary dipyridamole (0.5 mg/kg bodyweight)
Number of subjects: 1094

Group type: COMPARATOR
Intervention: Conventional pretreatment (heparin 15,000 IU and aspirin 500 mg intravenously)
Number of subjects: 1094
Study: 8635316

Group type: EXPERIMENTAL
Intervention: Consumer case managers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-consumer case managers
Number of subjects: 0
Study: 1358922

Group type: EXPERIMENTAL
Intervention: terazosin (2‐4 mg/day for 4 weeks)
Number of subjects: 12
Study: 4044461

Group type: EXPERIMENTAL
Intervention: Macrodantin (100 mg at night)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Trimethoprim (100 mg at night)
Number of subjects: 72
Study: 30636727

Group type: EXPERIMENTAL
Intervention: 4-week home-based treatment program including orthotics and strengthening exercises
Number of subjects: 35
Study: 29498348

Group type: EXPERIMENTAL
Intervention: 500 ml blood orange juice providing 50 mg anthocyanins/d
Number of subjects: 41

Group type: COMPARATOR
Intervention: 500 ml blonde orange juice without anthocyanins
Number of subjects: 41
Study: 27561137

Group type: EXPERIMENTAL
Intervention: Public health dose (16 kcal/kg/wk) of exercise for 12 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Low dose (4 kcal/kg/wk) of exercise for 12 weeks
Number of subjects: 122
Study: 24041737

Group type: COMPARATOR
Intervention: Clear liquid diet for 12 h on the day before (Group A)
Number of subjects: 198

Group type: COMPARATOR
Intervention: High volume polyethylene glycol (50 mL/kg, up to 2Lt/die) (Group B)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Low volume polyethylene glycol (25 mL/kg, up to 1Lt/die) (Group C)
Number of subjects: 198

Group type: COMPARATOR
Intervention: 20 mL (376 mg) of oral simethicone (Group D)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 25 mL/kg (up to 1Lt/die) of polyethylene glycol solution plus 20 mL (376 mg) of oral simethicone (Group E)
Number of subjects: 198
Study: 22513502

Group type: EXPERIMENTAL
Intervention: Tadalafil (10 to 20 mg, increased based on effects and adverse reactions)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 104
Study: 20551183

Group type: EXPERIMENTAL
Intervention: Antiangiogenic drugs (sorafenib [n = 10], sunitinib [n = 22])
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Interferon alfa (n = 7)
Number of subjects: 51
Study: 18948239

Group type: EXPERIMENTAL
Intervention: Amiodarone treatment (Group A)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: No amiodarone treatment (Group B)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group (no postoperative AF)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 296
Study: 16198876

Group type: EXPERIMENTAL
Intervention: AR index (echocardiographic parameters: jet width ratio, vena contracta width, pressure half‐time, jet density, diastolic flow reversal in the descending aorta)
Number of subjects: 79
Study: 11895046

Group type: EXPERIMENTAL
Intervention: P. ginseng 200 mg/d
Number of subjects: 30
Study: 10047624

Group type: EXPERIMENTAL
Intervention: High PRP group (PRP > 21,700)
Number of subjects: 6251

Group type: COMPARATOR
Intervention: Low PRP group (PRP <= 21,700)
Number of subjects: 6251
Study: 8570879

Group type: EXPERIMENTAL
Intervention: Escort spirometer
Number of subjects: 200

Group type: COMPARATOR
Intervention: mini-Wright peak flow meter
Number of subjects: 200

Group type: COMPARATOR
Intervention: Micromed turbine spirometer
Number of subjects: 200
Study: 1675036

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 6183864

Group type: EXPERIMENTAL
Intervention: Oral methoxsalen
Number of subjects: 26

Group type: COMPARATOR
Intervention: Topical trioxsalen
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: PUVA-exposed skin
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: PUVA treatment
Number of subjects: 26
Study: 31570024

Group type: EXPERIMENTAL
Intervention: Dilapan-S combined with mifepristone and misoprostol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Mifepristone and misoprostol only
Number of subjects: 74
Study: 31725473

Group type: EXPERIMENTAL
Intervention: Risperidone plus Propentofylline (300 mg/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Risperidone plus Placebo
Number of subjects: 48
Study: 29515144

Group type: EXPERIMENTAL
Intervention: Functional fitness (FF)
Number of subjects: 2096

Group type: EXPERIMENTAL
Intervention: 30s-arm curl
Number of subjects: 2096

Group type: EXPERIMENTAL
Intervention: Language
Number of subjects: 2096

Group type: EXPERIMENTAL
Intervention: Eight-foot up-and-go
Number of subjects: 2096

Group type: EXPERIMENTAL
Intervention: Orientation
Number of subjects: 2096

Group type: EXPERIMENTAL
Intervention: Recall
Number of subjects: 2096
Study: 26368833

Group type: EXPERIMENTAL
Intervention: Multimodal Cawthorne & Cooksey protocol (n = 42)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional Cawthorne & Cooksey protocol (n = 40)
Number of subjects: 82
Study: 24962502

Group type: EXPERIMENTAL
Intervention: Sexual minority girls (SMGs)
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Heterosexual girls with ARA exposure
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Sexual minority girls (SMGs) without ARA exposure
Number of subjects: 564
Study: 22223180

Group type: EXPERIMENTAL
Intervention: Rilonacept (320 mg loading dose followed by 160 mg weekly)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 20638409

Group type: EXPERIMENTAL
Intervention: Structured exercise schedules
Number of subjects: 140

Group type: COMPARATOR
Intervention: Non-structured exercise recommendations (Control)
Number of subjects: 140
Study: 17189087

Group type: EXPERIMENTAL
Intervention: Cereal-thickened formula
Number of subjects: 63

Group type: COMPARATOR
Intervention: Postural therapy
Number of subjects: 63
Study: 15279345

Group type: EXPERIMENTAL
Intervention: 0.5% plain bupivacaine infiltration
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (no bupivacaine)
Number of subjects: 142
Study: 12170040

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib, 20 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib, 40 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 10094236

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phenelzine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Antidepressants (at follow-up)
Number of subjects: 40
Study: 8586311

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TVS)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Transabdominal ultrasound (TAS)
Number of subjects: 91
Study: 2378770

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2.5 mg kg‐1 with adrenaline 5 micrograms ml‐1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bupivacaine 2.5 mg kg‐1 without adrenaline
Number of subjects: 12
Study: 796476

Group type: EXPERIMENTAL
Intervention: Aspartame (2.7 g/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 100

Group type: COMPARATOR
Intervention: Aspartame and placebo
Number of subjects: 100
Study: 30261781

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28242580

Group type: EXPERIMENTAL
Intervention: Tailored education program for falls prevention using home floor plans (n=25)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standard care (exercises) + Tailored education program (n=25)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care (exercises) (n=26)
Number of subjects: 60
Study: 25796408

Group type: EXPERIMENTAL
Intervention: 50:50 anorganic bovine bone and autologous bone
Number of subjects: 20

Group type: COMPARATOR
Intervention: anorganic bovine bone alone
Number of subjects: 20
Study: 23073395

Group type: EXPERIMENTAL
Intervention: Internet-based dyspnea self-management program (eDSMP)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Face-to-face dyspnea self-management program (fDSMP)
Number of subjects: 125

Group type: COMPARATOR
Intervention: General health education (GHE)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: DSMPs (eDSMP and fDSMP combined)
Number of subjects: 125
Study: 21718738

Group type: EXPERIMENTAL
Intervention: dTpa vaccine (Boostrix(®))
Number of subjects: 293
Study: 18637602

Group type: EXPERIMENTAL
Intervention: Combined intrathecal and epidural magnesium (50 mg of 5% Mg and 2% Mg at a rate of 100 mg/hr)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intrathecal 10 mg of Bupivacaine 0.5% plus 25 microg of Fentanyl plus 50 mg of 5% Mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intrathecal 10 mg of Bupivacaine 0.5% plus 25 microg of Fentanyl plus 0.9% NaCl solution
Number of subjects: 80
Study: 17160911

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenofibrate-statin combination therapy
Number of subjects: 0
Study: 15344449

Group type: EXPERIMENTAL
Intervention: Voxel-based cortical thickness estimation method
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group of 23 healthy subjects
Number of subjects: 50
Study: 12585144

Group type: EXPERIMENTAL
Intervention: Chemotherapy and GBYL (Group B)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Chemotherapy and GBYL plus moxibustion (Group C)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Chemotherapy and placebo (Group A)
Number of subjects: 81
Study: 9730668

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment, 0.2 IU/kg/body weight daily for 3 years
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (group 2) with 1-year observation followed by 3 years of GH treatment, 0.2 IU/kg/body weight daily
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both groups (GH treatment)
Number of subjects: 69
Study: 7992939

Group type: EXPERIMENTAL
Intervention: Orth‐Evac group (OGr)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Solcotrans Plus group (SGr)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CGr)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 30
Study: 2736968

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dopamine and Dobutamine
Number of subjects: 25
Study: 127655

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus RAJI immunotherapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Chemotherapy alone (Control)
Number of subjects: 16
Study: 31755166

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger (HME) worn during intense cold air exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: No heat and moisture exchanger (without HME) during intense cold air exercise
Number of subjects: 13
Study: 31109760

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intensity progression during cardiac rehabilitation
Number of subjects: 238
Study: 27912161

Group type: EXPERIMENTAL
Intervention: TaperGuard EVAC tube with subglottic suctioning every 6 hours
Number of subjects: 276

Group type: COMPARATOR
Intervention: Conventional tube
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: TaperGuard EVAC tube
Number of subjects: 276
Study: 26086641

Group type: EXPERIMENTAL
Intervention: VLBW children
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SGA children
Number of subjects: 120

Group type: COMPARATOR
Intervention: Term AGA children
Number of subjects: 120
Study: 23941313

Group type: EXPERIMENTAL
Intervention: Bupropion (active treatment)
Number of subjects: 792

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral smoking cessation treatment (CBT)
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment for depression
Number of subjects: 792

Group type: EXPERIMENTAL
Intervention: Standardized behavioral support
Number of subjects: 792
Study: 21623607

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 57

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both open and laparoscopic surgery
Number of subjects: 57
Study: 19561484

Group type: EXPERIMENTAL
Intervention: Lichtenstein's operation
Number of subjects: 2708

Group type: COMPARATOR
Intervention: mesh plug repair
Number of subjects: 2708

Group type: COMPARATOR
Intervention: PHS repair
Number of subjects: 2708
Study: 16688654

Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg
Number of subjects: 915

Group type: COMPARATOR
Intervention: omeprazole 20 mg
Number of subjects: 915
Study: 14565994

Group type: EXPERIMENTAL
Intervention: Resistance training combined with GH administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: GH administration alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Resistance training with placebo
Number of subjects: 0
Study: 11370690

Group type: EXPERIMENTAL
Intervention: Raspberry leaf tablets (2 x 1.2 g per day)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 9234828

Group type: EXPERIMENTAL
Intervention: Diltiazem 240 mg + Lisinopril 10 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg + Lisinopril 10 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Diltiazem 240 mg
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Lisinopril 10 mg
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 29669529

Group type: EXPERIMENTAL
Intervention: Patients Concerns Inventory (PCI) package
Number of subjects: 416
Study: 27113362

Group type: EXPERIMENTAL
Intervention: Tailored patient education intervention (nurse-conducted medication counselling, information booklet, video, website, text message reminders)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Tailored patient education intervention
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no tailored patient education)
Number of subjects: 86
Study: 24408401

Group type: EXPERIMENTAL
Intervention: Glucagon stimulation test (GST)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Mixed-meal tolerance test (MMTT)
Number of subjects: 343
Study: 22492424

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) 75 U/1.5 mL
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline (1.5 mL)
Number of subjects: 42
Study: 19664210

Group type: EXPERIMENTAL
Intervention: HIV-infected pregnant women
Number of subjects: 2659

Group type: EXPERIMENTAL
Intervention: HIV-infected infants
Number of subjects: 2659
Study: 16764647

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily for 14 days
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 15377480

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) administration after transplantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11486241

Group type: EXPERIMENTAL
Intervention: Uric acid, 1,000 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin C, 1,000 mg
Number of subjects: 0
Study: 9658668

Group type: EXPERIMENTAL
Intervention: dotarizine (50 mg b.i.d.)
Number of subjects: 110

Group type: COMPARATOR
Intervention: cinnarizine (75 mg b.i.d.)
Number of subjects: 110
Study: 7848586

Group type: COMPARATOR
Intervention: Air exposure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oxidants (0.12 ppm ozone plus 0.30 ppm nitrogen dioxide)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oxidants plus sulfuric acid at 70 micrograms/m3 of air
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oxidants plus 0.05 ppm nitric acid
Number of subjects: 28
Study: 3394909

Group type: EXPERIMENTAL
Intervention: 100 micrograms of fentanyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 250 micrograms of fentanyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 500 micrograms of fentanyl
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2 ml normal saline
Number of subjects: 60
Study: 31613050

Group type: EXPERIMENTAL
Intervention: Permethrin 2.5% with tea tree oil gel
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 47
Study: 31038461

Group type: EXPERIMENTAL
Intervention: Web-based self-management enhancing program (12 months access)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 157
Study: 28797867

Group type: EXPERIMENTAL
Intervention: Compression group (CG) with circular-knit sleeves in compression class I (15-21 mm Hg) for daily wearing (n=23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no CG) without compression (n=22)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups underwent a standardized physical exercise program
Number of subjects: 45
Study: 25697492

Group type: EXPERIMENTAL
Intervention: SMS reminder for breast self-examination (BSE) - one text message on the first day and another on the fifteenth day of every month for 6 months.
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (no SMS reminders).
Number of subjects: 202
Study: 23301947

Group type: EXPERIMENTAL
Intervention: Depression symptoms
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Mania-type symptoms
Number of subjects: 253
Study: 20331562

Group type: EXPERIMENTAL
Intervention: Diacetylmorphine (DAM)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 57

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 57
Study: 18645097

Group type: COMPARATOR
Intervention: Freshly reconstituted Botox (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2-week-old reconstituted Botox (experimental) stored at 4 degrees C (refrigerated)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2-week-old reconstituted Botox (experimental) stored at -20 degrees C (frozen)
Number of subjects: 40
Study: 17365349

Group type: EXPERIMENTAL
Intervention: Computer-based intervention
Number of subjects: 326

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 326
Study: 14764015

Group type: EXPERIMENTAL
Intervention: Acupuncture and care interventions
Number of subjects: 88

Group type: COMPARATOR
Intervention: Care interventions
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 88
Study: 11386263

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 2289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2289
Study: 9207701

Group type: COMPARATOR
Intervention: Neck resting at neutral position (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Passive hyperflexion of the neck
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hyperextension of the neck with simultaneous abdominal contraction
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sustained active neck hyperflexion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Active neck flexion (one-minute period) followed by repeated H reflex evocation at two-minute intervals
Number of subjects: 10
Study: 8256468

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy (600 mg of D‐alpha tocopherol per day, 200 micrograms of selenium, and 12 mg of zinc)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no antioxidant therapy)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy
Number of subjects: 56
Study: 3312029

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus flucloxacillin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus cephalothin
Number of subjects: 45
Study: 31971449

Group type: EXPERIMENTAL
Intervention: Duplicates of unselected patient samples
Number of subjects: 65000
Study: 31132331

Group type: EXPERIMENTAL
Intervention: NLP tool for identification of ILNs
Number of subjects: 950

Group type: COMPARATOR
Intervention: Fleischner reporting macro implementation (2017)
Number of subjects: 950
Study: 28577588

Group type: EXPERIMENTAL
Intervention: Standardized positive feedback
Number of subjects: 138

Group type: COMPARATOR
Intervention: Neutral feedback
Number of subjects: 138
Study: 25382414

Group type: EXPERIMENTAL
Intervention: Behavioral parent training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Binary segmentation procedure (SEARCH)
Number of subjects: 0
Study: 23514246

Group type: EXPERIMENTAL
Intervention: Primary radiotherapy (RT) ± chemotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Transoral robotic surgery (TORS) ± adjuvant [chemo] RT
Number of subjects: 68
Study: 21685642

Group type: EXPERIMENTAL
Intervention: Audio and video narrative on mobile phone (UMTS)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Audio and video narrative on DVD (DVD)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Audio narrative on MP3 player (M3)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Audio narrative on CD (CD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (CTRL)
Number of subjects: 75
Study: 19909492

Group type: EXPERIMENTAL
Intervention: Serial electrical muscle stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16963850

Group type: EXPERIMENTAL
Intervention: Anecortave acetate 30 mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Anecortave acetate 15 mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Anecortave acetate 3 mg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Anecortave acetate (all concentrations)
Number of subjects: 34
Study: 15072030

Group type: EXPERIMENTAL
Intervention: Levofloxacin 300 mg orally once daily (LEV group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanic acid 625 mg three times a day (COA group)
Number of subjects: 60
Study: 11458304

Group type: EXPERIMENTAL
Intervention: Women (intervention group)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Men (control group)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Both genders (overall comparison)
Number of subjects: 239